PARP1 and Cognitive impairment: Decreased TBARS, PARP activity, and NO levelIncreased GSH content and activities of GPx, glutathione reductase, and CATReduced the expression of COX-2, GFAP, IL-8, iNOS, and NF-kBImproved cognitive deficits